Close Menu
USA Biz News Stay Current on Economy News
  • Home
  • USA
  • World
  • Politics
  • Business
    • CEO
    • Realtor
    • Entrepreneur
    • Journalist
  • Sports
    • Athlete
    • Coach
    • Fitness trainer
  • Health
    • Doctor
    • Plastic Surgeon
    • Beauty Cosmetics
  • Economy
  • Life Style
Trending
  • Mr. Eric Y.S.: Anchoring Truth, Purpose, and Impact Through Storytelling
  • From Quiet Beginnings to Purpose-Driven Impact: The Inspiring Journey of Sarah Grace
  • The Journey of Danny B Musique: A Symphony of Passion, Perseverance, and Purpose
  • Novartis Gets Ready for Possible Trump Tariffs: A Pharma Giant on Alert.
  • The U.S. government is thinking about making a website, maybe even with Trump’s name on it, to help people find cheaper medicine.
  • Stocks Pop After Interest Rate Decrease: Great or Just for Wall Street?
  • Trump’s Policies Put Clean Energy Jobs in Danger.
  • Is America Headed Back to a McCarthy Era?   
USA Biz News Stay Current on Economy News
Tuesday, March 10
  • Home
  • USA
  • World
  • Politics
  • Business
    • CEO
    • Realtor
    • Entrepreneur
    • Journalist
  • Sports
    • Athlete
    • Coach
    • Fitness trainer
  • Health
    • Doctor
    • Plastic Surgeon
    • Beauty Cosmetics
  • Economy
  • Life Style
USA Biz News Stay Current on Economy News
Home » News » No workforce reduction: Dr. Reddy’s

No workforce reduction: Dr. Reddy’s

Jessica BrownBy Jessica Brown Business
Share
Facebook Twitter LinkedIn Pinterest Email

Dr. Reddy’s laboratories of Major Dr. Reddy have said on Monday that there was no reduction or a 25 percent workforce to reduce operating costs.

Reacting the reports in one section of the media, the company based in Hyderabad said: “We want to clarify that these news are in fact incorrect. We categorically deny the claim of a cost reduction of 25 per center and the other claimed in what was said.” ”

“The company does not comment on market speculation and currently there is no such event or information that requires a dissemination under regulation 30 of Sebi listing regulations,” the drug manufacturer reported to the bours.

Posted on April 14, 2025

Previous ArticleGreek police probe hardline group claims on bombing attacks | Police News
Next Article College basketball transfer portal team rankings for 9 best men’s classes so far

Keep Reading

Novartis Gets Ready for Possible Trump Tariffs: A Pharma Giant on Alert.

Trump’s Policies Put Clean Energy Jobs in Danger.

Argentina’s Soy Industry: Caught in the Crossfire of U.S.-China Trade Tensions.

Should Companies Ditch Quarterly Earnings Reports? Trump Thinks So.

People in the U.S. Are Feeling Less Hopeful in September: What It Means.

The Treasury Secretary Warns: Canceling Tariffs Could Be Really Expensive.

Most View

Novartis Gets Ready for Possible Trump Tariffs: A Pharma Giant on Alert.

September 20, 2025

Trump’s Policies Put Clean Energy Jobs in Danger.

September 19, 2025

Argentina’s Soy Industry: Caught in the Crossfire of U.S.-China Trade Tensions.

September 18, 2025
Latest Posts

Novartis Gets Ready for Possible Trump Tariffs: A Pharma Giant on Alert.

September 20, 2025

Trump’s Policies Put Clean Energy Jobs in Danger.

September 19, 2025

Argentina’s Soy Industry: Caught in the Crossfire of U.S.-China Trade Tensions.

September 18, 2025

Should Companies Ditch Quarterly Earnings Reports? Trump Thinks So.

September 16, 2025

USA

  • World
  • Politics
  • Economy
  • Life Style

Business

  • CEO
  • Realtor
  • Entrepreneur
  • journalist

Sports

  • Athlete
  • Coach
  • Fitness Trainer

Health

  • Doctor
  • Plastic Surgeon
  • Beauty Cosmetics
© 2017-2026 usabiznews. All Rights Reserved.

Type above and press Enter to search. Press Esc to cancel.